Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

Title
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 104, Issue 1, Pages 68-74
Publisher
Springer Nature
Online
2010-11-24
DOI
10.1038/sj.bjc.6605972

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation